CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cells
- PMID: 22962607
- PMCID: PMC3433478
- DOI: 10.1371/journal.pone.0044266
CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by Toll-like receptor-induced dendritic cells
Abstract
Background: Dendritic cells (DCs) determine the activation and polarization of T cells via expression of costimulatory molecules and secretion of cytokines. The function of DCs derived from monocytes ex vivo strongly depends on the composition of the maturation cocktail used.
Methodology/principal findings: We analyzed the effect of costimulatory molecule expression and cytokine secretion by DCs on T and natural killer (NK) cell activation by conducting a head-to-head comparison of a Toll-like receptor (TLR) agonist-based cocktail with the standard combination of proinflammatory cytokines or IL-10 alone. We could show that TLR-induced DCs are characterized by a predominance of costimulatory over coinhibitory molecules and by high secretion of IL-12p70, but not IL-10. Functionally, these signals translated into an increase in IFN-γ secreting Th1 cells and a decrease in regulatory T cells. T cell activation and polarization were dependent on IL-12p70 and CD86, but remarkably not on CD80 signaling. By means of IL-12p70 secretion, only TLR-induced DCs activated NK cells.
Conclusions/significance: TLR-matured DCs are highly suitable for application in immunotherapeutic strategies that rely on strong type 1 polarization and NK cell activation. Their effects particularly depend on high CD86 expression and IL-12p70 secretion.
Conflict of interest statement
Figures






Similar articles
-
Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.J Immunother. 2011 Apr;34(3):270-8. doi: 10.1097/CJI.0b013e31820b370b. J Immunother. 2011. PMID: 21389871 Free PMC article.
-
Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs.J Interferon Cytokine Res. 2015 Sep;35(9):748-58. doi: 10.1089/jir.2015.0022. Epub 2015 Jul 2. J Interferon Cytokine Res. 2015. PMID: 26134473
-
Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.J Immunother. 2009 Jun;32(5):524-38. doi: 10.1097/CJI.0b013e3181a28422. J Immunother. 2009. PMID: 19609245
-
Stability of Regulatory T Cells Undermined or Endorsed by Different Type-1 Cytokines.Adv Exp Med Biol. 2015;850:17-30. doi: 10.1007/978-3-319-15774-0_2. Adv Exp Med Biol. 2015. PMID: 26324343 Review.
-
Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.Cell Mol Life Sci. 2011 Nov;68(21):3505-18. doi: 10.1007/s00018-011-0801-8. Epub 2011 Aug 23. Cell Mol Life Sci. 2011. PMID: 21861182 Free PMC article. Review.
Cited by
-
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.J Immunother Cancer. 2022 Jun;10(6):e004268. doi: 10.1136/jitc-2021-004268. J Immunother Cancer. 2022. PMID: 35688559 Free PMC article.
-
Integrated analysis reveals the potential of cluster of differentiation 86 as a key biomarker in high-grade glioma.Aging (Albany NY). 2023 Dec 26;15(24):15402-15418. doi: 10.18632/aging.205359. Epub 2023 Dec 26. Aging (Albany NY). 2023. PMID: 38154107 Free PMC article.
-
Fcγ receptors and toll-like receptor 9 synergize to drive immune complex-induced dendritic cell maturation.Cell Immunol. 2019 Nov;345:103962. doi: 10.1016/j.cellimm.2019.103962. Epub 2019 Aug 3. Cell Immunol. 2019. PMID: 31582169 Free PMC article.
-
TLR7-Adjuvanted Ionizable Lipid Nanoparticles for mRNA Vaccine Delivery.AAPS J. 2025 Apr 25;27(4):80. doi: 10.1208/s12248-025-01073-2. AAPS J. 2025. PMID: 40281311
-
Natural killer cell-dependent anti-fibrotic pathway in liver injury via Toll-like receptor-9.PLoS One. 2013 Dec 10;8(12):e82571. doi: 10.1371/journal.pone.0082571. eCollection 2013. PLoS One. 2013. PMID: 24340043 Free PMC article.
References
-
- Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252. - PubMed
-
- Schuler G, Schuler-Thurner B, Steinman RM (2003) The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15: 138–147. - PubMed
-
- Banchereau J, Palucka AK (2005) Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5: 296–306. - PubMed
-
- Melief CJ (2008) Cancer immunotherapy by dendritic cells. Immunity 29: 372–383. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials